Elevated levels of HIF-1α subsequently stimulate the promotion of vascular endothelial growth factor and platelet-derived growth factor (PDGF) production, hence enhancing tumor angiogenesis (20–22). The gene discussed is HIF1A; the disease is neoplasm.